Tumor regression and other prognosticators in advanced head and neck cancers: a sequel to the RTOG methotrexate study
- 1 July 1983
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 9 (7), 957-964
- https://doi.org/10.1016/0360-3016(83)90382-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx: Concluding report of an rtog randomized trial on 638 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1980
- The place of irradiation in the management of the primary lesion in head and neck cancersCancer, 1977
- Carcinoma of the floor of mouth: an analysis of treatment results and the sites and causes of failuresInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancersInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic neck nodesInternational Journal of Radiation Oncology*Biology*Physics, 1976
- Postirradiation Induration as a PrognosticatorRadiology, 1972
- CANCER OF THE BASE OF THE TONGUEAmerican Journal of Roentgenology, 1969
- Prognostic Significance of Extent of Tumor Regression at Completion of Radiation TherapyRadiology, 1965